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Abstract
Background: Incidence and clinical characteristics of synchronous colorectal cancer (sCRC) patients significantly
vary among studies, likely due to differences in surveillance methodology. If remain undetected, sCRC can progress
to more advanced stages seriously aggravating patient prognosis. We studied the incidence and clinicopathological
characteristics of Japanese patients with sCRCs who underwent surgery for primary CRC and received exhaustive
perioperative surveillance.
Methods: We recruited 1005 patients with surgically resected CRCs between January 2007 and December 2011.
The associations of clinical and pathological factors with sCRC development were assessed by univariate and
multivariate logistic regression.
Results: Eighty-four patients (8.4 %) developed sCRCs, 16 of them (19.0 %) harboring three or more cancers. Companion
sCRCs were smaller and earlier stage than the index lesion (P < 0.0001). In multivariate analysis, advanced age
(odds ratio (OR) 1.03 per year; P = 0.009) and left colon tumor location (OR 1.78; P = 0.013) are associated with
higher risk of sCRCs, particularly in females. Overall survival did not differ between solitary CRC and sCRC (P = 0.62).
Conclusions: Our results highlight the importance of perioperative colonoscopy examination to ensure the absence
of sCRCs that, being small and early staged, are more difficult to detect. The incidence of sCRC, and notably of triple or
more sCRCs, was higher than previously recognized. Because they are also significantly higher than expected by merely
stochastic accumulation of individual cancerous lesions, we suggest that the occurrence of many sCRC reflects a
hitherto uncharacterized predisposition condition.
Keywords: Colorectal cancer, Synchronous colorectal cancer, Multiple colorectal cancers, Surgical resection, Colon
stenosis
Background
Colorectal cancer (CRC) is the second and third cause
of cancer death in male and female, respectively, in de-
veloped countries [1]. Although CRC incidence in Japan
and other Asian countries is lower than in western
countries, during the last few decades, it has been rapidly
increasing, according to recent reports from the World
Health Organization [2, 3]. The incidence of synchronous
CRC (sCRC) has been estimated to range between 1.1 and
8.1 %, with only small size studies reporting an incidence
higher than 4 % [4–20].
Well-established risk factors for sCRC development
are familial CRC syndromes, ulcerative colitis, and micro-
satellite instability (MSI) [13, 21]. A preoperative precise
diagnosis of sCRC is essential, because it may influence
clinical decision-making regarding the type and extension
of the surgical procedure as well as the use of additional
treatments. Furthermore, if overlooked, synchronous tu-
mors may require additional surgery and might grow into
more advanced stages ultimately leading to the develop-
ment of distant metastases.
The aim of this study was to investigate the incidence
rate of sCRCs in a consecutive series of non-familial
Japanese CRC patients and determine the clinical and
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pathological features of patients developing sCRCs, to esti-
mate the relative contribution of the different risk factors.
Methods
Patients
We reviewed 1022 consecutive patients that underwent
surgery for primary CRC in Saitama Medical Center, Jichi
Medical University, between January 2007 and December
2011. Seventeen cases were excluded from the analysis,
including suspected familial adenomatous polyposis syn-
drome (FAP, n = 4), hereditary nonpolyposis colorectal
cancer (HNPCC, n = 1), patients with history of previous
CRC (n = 9), and patients with ulcerative colitis (n = 3).
The remaining 1005 patients were included in this study.
Mean patient age was 67.4 ± 11.2 years and mean follow-
up interval was 44.3 ± 19.5 months.
In this study, only cancerous lesions histologically proven
were considered. Multiple CRC was defined according to
the criterion of Moertel et al. [22]: a pathologically proven
adenocarcinoma and distinctly separated from the previous
line of anastomosis. Cancers diagnosed within 6 months
before or after the initial diagnosis were considered as
sCRC. In sCRCs, the most pathologically advanced cancer
was designated as the index tumor. When more than one
tumor were diagnosed with identical pathological stage, the
largest one was considered the index tumor and the other
lesions were considered the companion tumors.
Colonoscopy was used as standard a preoperative sur-
veillance of the whole colon [23]. Some patients harbored
advanced tumors which prevented the advance of the col-
onoscope to more proximal colon, i.e., impassable stenosis.
These patients received an alternative surveillance modality,
e.g., 3DCT, barium enema study, colonoscopy after self-
expanding metallic stent (SEMS) placement across the
obstructing lesion, or intraoperative colonoscopy.
Tumor stage was defined according to the tumor, lymph
nodes, and metastasis (TNM) classification of the American
Joint Committee on Cancer (6th edition) [24]. Tumor lo-
cation was classified into three groups as follows: right
colon (appendix, cecum, ascending, hepatic flexure, and
transverse colon), left colon (splenic flexure, descending,
sigmoid, and rectosigmoid junction), and rectum.
Ethics approval and consent to participate
In this retrospective study, anonymized clinical informa-
tion from patients from the Saitama Medical Center,
Jichi Medical University, was employed. The study was
approved by the Research Ethics Committee at Saitama
Medical Center, Jichi Medical University, complying with
the ethical guidelines of the Declaration of Helsinki [25].
Statistical analysis
Categorical variables were compared using Fisher’s exact
test. Continuous variables were compared using t test
for those exhibiting a normal distribution, or Wilcoxon-
Mann–Whitney test for those that deviated from a normal
distribution. Deviation from normality was determined by
Shapiro’s test. Differences in survival were studied using
Cox’s proportional hazards regression model. Differences
were considered statistically significant at P < 0.05. The
concordance between locations of sCRCs for the same
individual was analyzed using Kappa (K) statistic. Ac-
curacy was considered poor when K was less than 0.20,
fair to good when K was between 0.20 and 0.40, and
good when K was larger than 0.40 [15]. All statistical
analyses were performed using R (ver.3.1.2.) [26] and
OpenEpi web server [27].
Results
Clinical and pathological features of sCRCs
Among 1005 patients who underwent surgery for CRC,
84 patients (8.4 %) developed sCRCs (Table 1). Of these,
16 patients (19.0 %) harbored triple or more sCRCs as
follows: triple sCRCs occurred in eight patients, quadruple
in seven, and quintuple in one. In total, 193 sCRCs were
detected in these 84 patients. Table 1 summarizes the
differences between patients with solitary CRC and pa-
tients with sCRC. Three factors were statistically sig-
nificant in these univariate analyses: gender (P = 0.044),
age (P = 0.028), and tumor location (P = 0.031). Other
clinicopathogical features such as tumor size, T stage,
tumor differentiation, status of lymph node metastasis
status, and frequency of extracolonic malignancies were
not different between sCRC and solitary CRC. Overall
survival of sCRC patients was also similar to that of
solitary CRC patients (P = 0.62) (Fig. 1). Multivariate lo-
gistic regression analysis using gender, age, and tumor
location as explanatory variables confirmed that these
three factors independently associated with sCRCs risk
(Table 2). When patients were stratified according to
gender, both age and tumor location retained statistical
significance in women but not in men (Table 2).
Incidence of sCRCs is not explained by stochastic
accumulation of lesions
The incidence of sCRC among patients (84 in 1005) was
more than twofold higher than predicted by purely sto-
chastic accumulation of cancerous lesions considering the
reported CRC incidence in the Japanese population [28],
after adjusting by age and gender (standardized incidence
ratio (SIR) = 2.2; confidence interval (CI) = 1.75–2.69; P =
2.1 × 10−10). Moreover, among the 84 sCRC patients, 16
had 3 or more sCRC, an incidence 2.3-fold higher than
expected under the assumption that sCRC lesions would
occur independently with the probability of 0.084 per
cancer (expected = 7; CI = 2–13; binomial distribution;
P = 9.4 × 10−4). A more refined analysis adjusting by age
(in 10-year bins) and gender confirmed a 2.2-fold higher
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risk of additional companion carcinomas in patients that
already harbored one index sCRC (SIR = 2.16; CI = 1.43–
3.14; P = 6 × 10−4).
Incidence of sCRC in older vs. younger patients
Familial CRC has been associated with a higher incidence
of sCRC [13]. Self-reported familial cases were excluded
from our analyses (see the “Methods” section). However,
the proportion of HNPCC cases among the initially re-
cruited 1022 patients was very low (n = 1, 0.1 %), even for
the Japanese population [8]. In the self-reported 1005
non-familial cases included in the analysis, there were 73
patients (7.3 %) younger than 50 years (Additional file 1:
Figure S1), a few of which could correspond to unreported
cases with family history of cancer. To assess whether the
inclusion of these patients might be associated with the
high incidence of sCRC found in our study, we compared
the sCRC incidence in patients older vs. younger than
50 years. Notably, sCRC incidence was higher in older
(83/932, 8.9 %) than in younger (1/73, 1.4 %) patients
(odds ratio (OR) = 7.03; CI = 1.2–284.9, P = 0.02). Similar
results were obtained when cutting at a higher age thresh-
old of 60 years: 75/786 (9.5 %) in older vs. 9/219 (4.1 %) in
younger patients (OR = 2.46; CI = 1.2–5.7; P = 0.008).
Diagnosis and treatments of patients with sCRCs
The vast majority of the sCRCs were diagnosed preopera-
tively (n = 185, 95.9 %), either by standard preoperative
colonoscopy (n = 179, including the 84 index lesions and
94 synchronous lesions), by barium enema (three tumors
in two patients), 3DCT (two tumors in two patients), or
by intraoperative colonoscopy (one tumor in one patient).
SEMS were placed in six stenotic patients, but none of
them were found to harbor sCRCs. Only eight sCRCs
(4.1 %) were incidentally identified by postoperative
pathological analysis in four patients (Table 3).
Secondary, tertiary, or quaternary sCRCs were signifi-
cantly smaller and less advanced than the index tumor
(Table 3). sCRCs tended to occur in the same surgical seg-
ment, with a fair to good association (K = 0.30, P = 0.0001)
(Table 4). However, 43 patients (51.2 %) developed sCRCs
in different surgical segments.
sCRCs were treated by endoscopy (36 tumors in 24
patients), by standard surgery (125 in 69 patients) or by
extended surgery (32 tumors in 15 patients). All patients
in which endoscopical resection of the companion sCRCs
was performed subsequently underwent standard surgery
for the resection of the index lesion (Table 3). We found
no difference in survival between patients who underwent
extended surgery compared to patients with standard
surgery (P = 0.91).
Examination and treatment of patients with impassable
stenosis
In this series, 139 patients harbored locally advanced
tumors in the left colon or rectum narrowing the lumen
and preventing the passage of the colonoscope (impass-
able stenosis), thus hampering the detection of possible
Table 1 Clinical and pathological characteristics of patients with
solitary vs. synchronous CRC
Solitary CRC Synchronous CRC P value*
(921 cases;
93.6 %)
(84 cases; 8.4 %)
Gender (male/female), no. 575/346 62/22 0.044
Mean age, years ± SD 67.1 ± 11.3 70.3 ± 9.5 0.028†
Follow-up months ± SD 44.6 ± 19.5 41.6 ± 18.7 0.097†
Location of solitary 0.031‡
Right side 308 (33.4 %) 26 (31.0 %)
Left side 282 (30.6 %) 37 (44.0 %)
Rectum 331 (35.9 %) 21 (25.0 %)
Average size; mm± SD 44.4 ± 25.6 43.8 ± 19.0 0.55†
T factor 0.26†
Tis 32 (3.5 %) 0
T1 94 (10.2 %) 7 (8.3 %)
T2 136 (14.8 %) 12 (14.3 %)
T3 443 (48.1 %) 49 (58.3 %)
T4 213 (23.1 %) 16 (19 %)
No residual/uncertain§ 3 (0.3 %) 0
Differentiation 0.25
pap + wel +mod 883 (95.9 %) 83 (98.8 %)
poor + muc + sig 38 (4.1 %) 1 (1.2 %)
Lymph node metastasis 0.81
N0 573 (62.2 %) 51 (60.7 %)
N1/2/3/4 348 (37.8 %) 33 (39.3 %)
Stage, no. 0.45
0 32 (3.2 %) 0
I 185 (18.4) 15 (17.9 %)
II 322 (35.0 %) 31 (36.9 %)
III 270 (29.3 %) 26 (31.0 %)
IV 112 (12.2 %) 12 (14.3 %)
Survival ratio 0.62||
3 years 83.1 % 81.0 %
5 years 75.7 % 74.5 %
Extracolonic malignancies 0.85
No 828 (89.9 %) 75 (89.3 %)
Yes 93 (10.1 %) 9 (10.7 %)
Values in parentheses are percentages unless indicated otherwise




‡Significance between the rectum and left side
§Numbers of no residual/uncertain were not included in the calculation
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sCRCs developing at more proximal locations. Of these,
54 patients received 3DCT analysis and one synchronous
tumor was detected, 53 patients underwent barium enema
study and two synchronous tumors were found, four
underwent colonoscopy after SEMS placement across the
obstructing lesion and no synchronous tumors were found,
and five underwent intraoperative colonoscopy and one
synchronous tumor was found. The other 23 patients could
not receive any additional analysis of the proximal colon. In
these patients, three synchronous tumors were incidentally
found by pathological reports after surgery. In total, only
four of the 139 (2.9 %) distal-stenotic CRC patients devel-
oped sCRCs in the proximal colon.
Discussion
The incidence of sCRC (8.4 %) in our group of 1005 CRC
patients is higher than that found in most of previous
series [4–20] and significantly higher than expected by
stochastic accumulation of cancerous lesions considering
the incidence of CRC in the general population of Japan
(SIR = 2.2; CI = 1.75–2.69; P = 2.1 × 10−10). In this regard,
our data is consistent with the long-standing but still
unresolved observation that cancer patients are at higher
risk of developing second independent malignancies that
cancer-naïve individuals [29]. Moreover, the incidence of
triple or more sCRC patients in our study (16 in 1005,
1.6 %) was significantly higher than previously reported
(0.1–0.7 %, P = 9.6 × 10−4) [9, 10, 13–15, 18] and 2.2-fold
higher than expected by stochastic accumulation of in-
dependent cancers. Thus, patients who developed one
sCRC were at increased risk of developing additional
synchronous malignancies. The higher propensity to de-
velop independent cancers in cancer patients compared
with the general population, and within them the exist-
ence of patients with even higher propensity to multiple
CRCs, further supports that genetic and environmental
risk factors, and not only stochastic molecular mecha-
nisms, underlie cancer susceptibility [30].
Age at diagnosis was an independent risk factor for
the occurrence of sCRC when considering men and women
together (Table 2). This observation is also in agreement
with most previous reports [15, 17, 19, 20]; however, some
reports did not find an association, or even found a reverse
association, between age and synchronous CRC develop-
ment [9, 11]. Notably, when stratifying the patients accord-
ing to gender, we found that age was a stronger risk factor
in women than in men (Table 2). To the best of our
Fig. 1 Overall survival of CRC patients with solitary (in black) or synchronous CRCs (in red) (P = 0.62, log-rank test)
Table 2 Multivariate logistic regression analysis of risk factors
for the development of synchronous CRC
Group Factor Odds ratio (95 % CI) P value
All patients (n = 1005) Gender (male) 1.67 (1.02–2.84) 0.047
Age 1.03 (1.01–1.05) 0.009
Location (left) 1.78 (1.12–2.81) 0.013
Men (n = 637) Age 1.02 (0.99–1.05) 0.16
Location (left) 1.60 (0.93–2.72) 0.08
Women (n = 368) Age 1.06 (1.02–1.11) 0.010
Location (left) 2.62 (1.05–6.41) 0.035
In italics, P values <0.05
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knowledge, no previous report mentioned this gender dis-
parity in the association between age and sCRC risk.
CRC patients with family history of cancer have a higher
predisposition to develop sCRC [13]. In our study, all pa-
tients with self-reported or diagnosed familial syndromes
were excluded (FAP or HNPCC, see the “Methods” sec-
tion). However, the information regarding family history
was essentially based on self-reported, possibly inaccurate,
testimonials from the patients. Due to the retrospective
design, we could not obtain more detailed and accurate
information. The incidence of confirmed HNPCC in our
series was 0.1 %, which is low even when considering that
Table 3 Pathological findings, surveillance, and treatment methods of synchronous CRC patients
Index S2 S3 S4 S5
Number of patients 84 84 16 8 1
Location of tumor
Right side 26 31.0 %) 31 (36.9 %) 3 (18.8 %) 1 (12.5 %) 1
Left-side 37 (44.0 %) 37 (44.0 %) 10 (62.5 %) 7 (87.5 %) 0
Rectum 21 (25.0 %) 16 (19.0 %) 3 (18.8 %) 0 0
P value 0.58 0.47 0.081
Average size, mm ± SD 43.8 ± 19.0 23.9 ± 15.1 18.0 ± 8.3 14.9 ± 1.5 15
P value* <0.001 <0.001 <0.001 N.A.
T stage
Tis 0 (0 %) 39 (46.4 %) 11 (68.8 %) 6 (75 %) 1
T1 7 (8.3 %) 23 (27.4 %) 4 (25 %) 1 (12.5 %) 0
T2 12 (14.3 %) 8 (9.5 %) 1 (6.25 %) 0 0
T3 49 (58.3 %) 10 (11.9 %) 0 0 0
T4 16 (19 %) 1 (1.2 %) 0 0 0
No residual/uncertaina 0 3 (3.6 %) 0 1 (12.5 %) 0
P value <0.001 <0.001 <0.001 N.A.
Histological type
pap + well + mod 83 (98.8 %) 81 (96.4 %) 14 (87.5 %) 6 (75 %) 0
poor +muc + sig 1 (1.2 %) 0 0 0 0
Others/no residual/uncertain† 0 3 (3.6 %) 2 (12.5 %) 2 (25 %) 1
P value 1 1 1 N.A.
Diagnosis methods
Endoscopy (pre-op) 84 (100 %) 75 (89.3 %) 12 (75 %) 7 (87.5 %) 1
3DCT 0 2 (2.4 %) 0 0 0
Barium enema study 0 2 (2.4 %) 1 (6.25 %) 0 0
Endoscopy (intra-op) 0 1 (1.2 %) 0 0 0
Post-op pathologically 0 4 (4.8 %) 3 (18.8 %) 1 (12.5 %) 0
Treatment methods
Endoscopic resection 0 24 (28.6 %) 6 (37.5 %) 5 (62.5 %) 1
Normal surgery 69 (82.1 %) 45 (53.6 %) 9 (56.3 %) 2 (25 %) 0
Extended surgery 15 (17.9 %) 15 (17.9 %) 1 (6.25 %) 1 (12.5 %) 0
Values in parentheses are percentages unless otherwise indicated
P values were calculated comparing to index tumor using Fisher’s exact test except for *Mann–Whitney test
In italics, P values <0.05
aNumbers of others/no residual/uncertain were not included in the calculation
Table 4 Location of index and companion synchronous CRCs
Companion synchronous tumor location
Index tumor location Right colon Left colon Rectum Ka
Right colon (n = 26) 17 11 2
Left colon (n = 37) 10 35 8
Rectum (n = 21) 8 9 9 0.30
aUnweighted Cohen’s kappa: P = 0.0001
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the incidence of HNPCC has been reported to be as low
as 0.4 % in Japan [8], certainly much lower than in North
American or European populations (1–3 %) [8, 31, 32].
It is therefore possible that a few individuals classified
as non-familial cases were actually undiagnosed HNPCC
patients.
We then analyzed the incidence of sCRC in patients
older vs. younger than 50 years, taking into account that
most HNPCC patients develop CRC before that age
[31, 33]. Notably, the incidence of sCRC was higher in
older patients (OR = 7.03; CI = 1.2–284.9, P = 0.02). In
addition, HNPCC tumors preferentially develop in the
right side colon, but in our study, most of the sCRCs
(68.4 %) developed in the left colon or rectum. Taking
these observations together, it seems unlikely that the
high sCRC incidence found in our series was due to inad-
vertently inclusion of familial CRC patients in the study.
Previous studies reported that sCRC develops in the
right colon more frequently than solitary CRC, although
this association has not been confirmed in other studies
[7, 12]. In our series, we found no difference in the fre-
quency of solitary vs. synchronous CRCs developing in
the right colon. However, we found a higher incidence of
sCRCs in the left colon (comprising descending and sig-
moid colon) and a lower incidence in the rectum (Table 1).
In our series, sCRCs often developed closely to each other,
facilitating in some cases clinical and pathological detec-
tion (Table 4). However, 43 patients (51 %) harbored
sCRCs in separate surgical segments, a proportion that is
in line with previous findings (43 to 78 %) [6, 34]. In 28 of
these patients, sCRCs could be resected by endoscopy
combined with standard surgery. In the remaining 15
patients, however, extended surgery was performed to
resect all the lesions.
We found no significant differences in size or stage
between the sCRC index lesions (the larger and more
advanced among the sCRCs) and solitary cases (Table 1).
On the other hand, the companion sCRCs were smaller
and less advanced than both the index lesions (Table 3)
and the solitary tumors, in agreement with previous re-
ports [5, 9, 16, 34]. Small or early CRCs are more likely to
be overlooked in the preoperative surveillance [35, 36].
Some of the tumors found during the postoperative
follow-up (metachronous) might be in fact overlooked
sCRCs, although it is difficult to distinguish metachro-
nous and sCRC with precision [37].
A common reason why synchronous lesions may be
missed is impassable stenosis due to large tumors in the
distal side of colon, preventing the lesions in the prox-
imal colon from being examined [7]. If a patient cannot
undergo complete examination of the large bowel before
the surgery, colonoscopy analysis is required during, or
as soon as possible after surgery: otherwise, the overlooked
tumors might advance and reach an unresectable status.
Among 1005 cases, total colonoscopy could not be per-
formed in 227 patients (22.6 %) due to impassable stenosis.
This was not a serious concern when occurring in the
right side colon (n = 88), because the whole proximal
colon would be resected during the standard surgical
right hemicolectomy. When the advanced lesion was
located in left colon or rectum (n = 139), however, the
patients underwent other modality of surveillance to
decide the most appropriate surgical treatment. Among
these patients, sCRCs were detected in the proximal
colon of five patients: in two cases by using 3DCT, one
by barium study, one by intraoperative colonoscopy,
and one was incidentally detected in the post-surgery
pathological analysis. Since there are some difference of
detection rate among 3DCT, barium enema, and colon-
oscopy [38], we confess the possibility that some sCRC
might have been missed among the patients with im-
passable stenosis.
The prognosis of patients with sCRC, compared with
patients with solitary CRC, is unclear. It has been docu-
mented to be better, the same, or worse, depending on the
study [15, 39]. This variation is likely caused by differences
in sample size, length of follow-up, and other factors such
as different proportion of advanced vs. early tumors and,
therefore, needs to be interpreted with caution. In our
study, we found no difference in tumor size, stage, differ-
entiation, or in survival rates between solitary and sCRC
patients (Table 1). The most important complications
associated with sCRC in comparison with solitary CRC
derive mainly from the higher propensity of these pa-
tients to develop metachronous tumors [40] as well as
the possibility of overlooking small or difficult to access
synchronous lesions that might later develop into more
advanced cancers.
Conclusions
We show that the sCRC incidence is higher than that of
most previous reports. Triple or more sCRCs were also
detected more frequently than in previous studies. We
studied a relatively large consecutive series of CRC pa-
tients that, in contrast with other reports, underwent
throughout perioperative examination by several comple-
mentary methodologies to minimize the accidental over-
looking of sCRC lesions. Since false positives are absent in
our study, as all identified lesions were histologically
proven, it seems more likely that the lower frequency re-
ported is due to the presence of false negatives in some
previous studies. Ethnic factors may also influence the
actual incidence differences, and a further examination of
this issue is warranted.
Our results strengthen the importance of a thorough,
extensive examination to avoid overlooking small or early-
staged synchronous lesions. When the locally advanced
tumor narrows the lumen and prevents the passage of the
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colonoscope, it is recommended to analyze the prox-
imal colon by other methodologies in order to decide
the most appropriate surgical procedure. Patients that
cannot undergo complete colon surveillance need to be
studied as soon as possible after surgery to rule out the
existence of sCRCs.
Our results are also valuable at a more fundamental
level, showing that the sCRC incidence cannot be explained
just by the stochastic accumulation of individual cancerous
lesions and consequently of the underlying somatic cancer-
driving genomic alterations. We conclude that this can
be explained by the existence of uncharacterized under-
lying genetic, environmental, or both, susceptibility fac-
tors for multiple CRC.
Additional file
Additional file 1: Figure S1. Age distribution of the CRC patients in
the 1005 cases consecutive series recruited for this work. Blue line: men.
Red line: women. Seventy-three patients were younger than 50 years
(left of the dashed line), and 932 patients were older than 50 years.
(PDF 91 kb)
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